152 related articles for article (PubMed ID: 17240625)
21. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
22. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
23. Platelet glycoprotein IIIa gene expression in normal and malignant megakaryopoiesis.
Ficko T
Ann Hematol; 2008 Feb; 87(2):131-7. PubMed ID: 17952438
[TBL] [Abstract][Full Text] [Related]
24. Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications.
Tefferi A; Silverstein MN; Petitt RM; Mesa RA; Solberg LA
Semin Thromb Hemost; 1997; 23(4):379-83. PubMed ID: 9263355
[TBL] [Abstract][Full Text] [Related]
25. Primary and secondary thrombocytosis in childhood.
Dame C; Sutor AH
Br J Haematol; 2005 Apr; 129(2):165-77. PubMed ID: 15813844
[TBL] [Abstract][Full Text] [Related]
26. Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.
Higgs JR; Sadek I; Neumann PE; Ing VW; Renault NK; Berman JN; Greer WL
Leukemia; 2008 Aug; 22(8):1551-6. PubMed ID: 18496561
[TBL] [Abstract][Full Text] [Related]
27. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia.
Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K
Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068
[TBL] [Abstract][Full Text] [Related]
28. Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia.
Tomita N; Motomura S; Sakai R; Fujimaki K; Tanabe J; Fukawa H; Harano H; Kanamori H; Ogawa K; Mohri H; Maruta A; Kodama F; Ishigatsubo Y; Tahara T; Kato T
Am J Hematol; 2000 Mar; 63(3):131-5. PubMed ID: 10679802
[TBL] [Abstract][Full Text] [Related]
29. Role of platelet counts in the management of essential thrombocythemia: experience with anagrelide.
Griesshammer M
Expert Rev Hematol; 2009 Jun; 2(3):227-36. PubMed ID: 21082965
[TBL] [Abstract][Full Text] [Related]
30. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Lindstedt G; Stockelberg D; Wadenvik H; Kutti J
Leuk Lymphoma; 2001 May; 41(5-6):579-84. PubMed ID: 11378575
[TBL] [Abstract][Full Text] [Related]
31. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.
Komatsu N; Nakauchi H; Miwa A; Ishihara T; Eguchi M; Moroi M; Okada M; Sato Y; Wada H; Yawata Y
Cancer Res; 1991 Jan; 51(1):341-8. PubMed ID: 1824823
[TBL] [Abstract][Full Text] [Related]
33. [Megakaryocyte development and platelet production in normal and disease states].
Deutsch V; Katz BZ; Tomer A
Harefuah; 2010 May; 149(5):291-7, 336. PubMed ID: 20929068
[TBL] [Abstract][Full Text] [Related]
34. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
Griesshammer M; Bangerter M; Schrezenmeier H
Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of essential thrombocythemia with anagrelide: a ten-year experience].
Kornblihtt LI; Vassallu PS; Heller P; Molinas FC
Medicina (B Aires); 2002; 62(3):231-6. PubMed ID: 12150005
[TBL] [Abstract][Full Text] [Related]
36. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
[TBL] [Abstract][Full Text] [Related]
37. The role of cytokines and transcription factors in megakaryocytopoiesis.
Yang M; Li K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):580-5. PubMed ID: 12513728
[TBL] [Abstract][Full Text] [Related]
38. [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
Penka M; Doubek M; Schwarz J; Pytlík R; Dulícek P; Kissová J; Hlusí A; Vozobulová V; Cerná O; Brychtová Y; Szotkowski T; Volková Z; Seghetová J; Schutzová M; Hadacová I; Hochová I; Voglová J; Siroký O; Belada D; Lhot'anová T; Bubeník B; Vránová M; Micaníková M; Dusek L
Vnitr Lek; 2006 May; 52(5):498-503. PubMed ID: 16771099
[TBL] [Abstract][Full Text] [Related]
39. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
LaIuppa JA; Papoutsakis ET; Miller WM
Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
[TBL] [Abstract][Full Text] [Related]
40. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
